Hyperion Therapeutics, Inc.
Industry
- Biotechnology
- Pharmaceuticals
Other Names/Subsidiaries
- Andromeda Biotech Ltd.
Latest on Hyperion Therapeutics, Inc.
Horizon Pharma PLC will continue to grow its orphan drug portfolio through acquisitions like the $800m purchase of Raptor Pharmaceutical Corp. announced on Sept. 12, but Horizon's primary care b
A poor first quarter for Dublin, Ireland-headquartered Horizon Pharma PLC 's primary care business leading it to lower its full-year revenue guidance and causing a 35% share price plunge on May 8 h
Evotec AG and Sanofi will jointly develop a beta cell replacement therapy to restore function in diabetic patients under an alliance announced Aug. 7. The deal widens existing areas of cooperati
Financings Representing a 72% increase over Q4 2014, first-quarter 2015 financing totaled $15.1 billion and featured 187 transactions (52 more than Q4). ( See Exhibit 1. ) Exhibit 1 Q1 2015 Biopharma